OQROGet OQRO Pro
Insider trade

Biocardia (BCDA)Director bought ~$2.5K

Simon H Stertzer, Director at Biocardia, bought ~$2.5K of Biocardia shares.

~$2.5K
Approx. value · 1,000 sh @ $2.45
57K
Holds after · shares reported
Traded
Mar 5, 2025
Filed
Mar 7, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 29, 2025InsiderCEO purchased ~$1.2K of BCDA shares in the open market
  2. Jan 30, 2025InsiderCEO purchased ~$569 of BCDA shares in the open market
  3. Feb 7, 2025InsiderCEO purchased ~$1.5K of BCDA shares in the open market
  4. Mar 3, 2025Insider · 2 peopleInsiders: 2 purchases (~$53K)
  5. Mar 4, 2025InsiderDirector purchased ~$36K of BCDA shares in the open market
  6. Mar 5, 2025 · this disclosureInsiderDirector purchased ~$2.5K of BCDA shares in the open market

What came next

  1. Apr 2, 2025InsiderCEO purchased ~$1.1K of BCDA shares in the open market
  2. Apr 3, 2025Insider · 1 personInsiders: 2 purchases (~$4K)
  3. Apr 4, 2025InsiderCEO purchased ~$1.6K of BCDA shares in the open market
  4. Apr 7, 2025InsiderCEO purchased ~$980 of BCDA shares in the open market
  5. Apr 10, 2025InsiderCEO purchased ~$597 of BCDA shares in the open market
  6. Apr 11, 2025InsiderCEO purchased ~$609 of BCDA shares in the open market
  7. Apr 15, 2025InsiderCEO purchased ~$214 of BCDA shares in the open market
  8. Apr 23, 2025Insider · 6 peopleInsiders: 6 purchases (~$575K)
  9. May 14, 2025InsiderCEO purchased ~$299 of BCDA shares in the open market
  10. May 16, 2025InsiderCEO purchased ~$730 of BCDA shares in the open market
  11. May 20, 2025InsiderCEO purchased ~$3.3K of BCDA shares in the open market
  12. May 22, 2025InsiderCEO purchased ~$1.3K of BCDA shares in the open market
  13. May 30, 2025InsiderCEO purchased ~$221 of BCDA shares in the open market
  14. Jun 30, 2025Insider · 4 peopleInsiders: 4 purchases (~$360K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Biocardia

For Biocardia, OQRO holds 9 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BCDA page.

Other recent filings by Simon H Stertzer, Director

The full history of Simon H Stertzer, Director is on the profile page.

How this filing works

Other disclosures at Biocardia

Everything OQRO holds on this company is on its BCDA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data